PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Gilead Sciences, Inc. (1GILD.MI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

Sector

Healthcare

Highlights

Market Cap

€110.95B

EPS (TTM)

€0.09

PE Ratio

978.78

PEG Ratio

0.52

Year Range

€56.61 - €91.88

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Gilead Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
36.87%
9.02%
1GILD.MI (Gilead Sciences, Inc.)
Benchmark (^GSPC)

Returns By Period

Gilead Sciences, Inc. had a return of -0.27% year-to-date (YTD) and 17.11% in the last 12 months.


1GILD.MI

YTD

-0.27%

1M

1.93%

6M

36.87%

1Y

17.11%

5Y*

14.22%

10Y*

N/A

^GSPC (Benchmark)

YTD

-0.66%

1M

-3.44%

6M

3.10%

1Y

22.14%

5Y*

12.04%

10Y*

11.24%

*Annualized

Monthly Returns

The table below presents the monthly returns of 1GILD.MI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-1.53%-7.62%3.27%-10.40%-4.53%11.30%11.72%-0.38%6.38%8.92%7.30%2.00%26.24%
2023-3.50%-1.68%-0.48%-0.72%-2.89%-1.05%-2.04%3.42%1.91%1.67%-4.37%5.71%-4.43%
2022-6.82%-12.75%3.05%8.96%3.47%-1.28%-0.90%6.97%3.57%24.68%3.50%-2.86%28.34%
202116.37%-5.36%9.65%-5.61%4.50%7.21%-0.90%6.24%1.76%-9.69%12.52%5.12%46.14%
2020-3.65%9.47%11.60%10.71%-11.47%0.71%-13.15%-6.29%-1.56%-7.44%1.19%-6.57%-18.54%
201910.55%-6.25%2.77%0.00%-3.45%6.37%-1.68%-0.33%0.93%-1.07%6.73%-2.18%11.76%
20188.58%-4.89%-8.43%1.33%-5.57%6.06%7.92%0.00%-0.77%-0.93%-1.57%-11.70%-11.50%
2017-5.40%-6.63%6.59%-5.85%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 1GILD.MI is 69, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 1GILD.MI is 6969
Overall Rank
The Sharpe Ratio Rank of 1GILD.MI is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of 1GILD.MI is 6666
Sortino Ratio Rank
The Omega Ratio Rank of 1GILD.MI is 6666
Omega Ratio Rank
The Calmar Ratio Rank of 1GILD.MI is 7474
Calmar Ratio Rank
The Martin Ratio Rank of 1GILD.MI is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Gilead Sciences, Inc. (1GILD.MI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for 1GILD.MI, currently valued at 0.68, compared to the broader market-2.000.002.000.681.74
The chart of Sortino ratio for 1GILD.MI, currently valued at 1.12, compared to the broader market-4.00-2.000.002.004.001.122.35
The chart of Omega ratio for 1GILD.MI, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.32
The chart of Calmar ratio for 1GILD.MI, currently valued at 0.64, compared to the broader market0.002.004.006.000.642.62
The chart of Martin ratio for 1GILD.MI, currently valued at 1.22, compared to the broader market0.0010.0020.001.2210.82
1GILD.MI
^GSPC

The current Gilead Sciences, Inc. Sharpe ratio is 0.68. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Gilead Sciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.68
2.27
1GILD.MI (Gilead Sciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

Gilead Sciences, Inc. provided a 3.06% dividend yield over the last twelve months, with an annual payout of €2.71 per share.


1.00%2.00%3.00%4.00%€0.00€0.50€1.00€1.50€2.00€2.5020172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017
Dividend€2.71€2.71€2.58€2.65€2.05€2.02€2.01€1.65€0.38

Dividend yield

3.06%3.05%3.52%3.33%3.16%4.35%3.41%3.01%0.59%

Monthly Dividends

The table displays the monthly dividend distributions for Gilead Sciences, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025€0.00€0.00
2024€0.00€0.00€0.65€0.00€0.00€0.67€0.00€0.00€0.70€0.00€0.00€0.70€2.71
2023€0.00€0.00€0.65€0.00€0.00€0.64€0.00€0.00€0.66€0.00€0.00€0.63€2.58
2022€0.00€0.00€0.61€0.00€0.00€0.67€0.00€0.00€0.73€0.00€0.00€0.64€2.65
2021€0.00€0.00€0.50€0.00€0.00€0.48€0.00€0.00€0.51€0.00€0.00€0.56€2.05
2020€0.00€0.00€0.54€0.00€0.00€0.53€0.00€0.00€0.48€0.00€0.00€0.46€2.02
2019€0.00€0.00€0.49€0.00€0.00€0.49€0.00€0.00€0.52€0.00€0.00€0.51€2.01
2018€0.00€0.00€0.37€0.00€0.00€0.42€0.00€0.00€0.42€0.00€0.00€0.44€1.65
2017€0.38€0.38

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%3.1%
Gilead Sciences, Inc. has a dividend yield of 3.06%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%33.6%
Gilead Sciences, Inc. has a payout ratio of 33.62%, which is quite average when compared to the overall market. This suggests that Gilead Sciences, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-3.34%
-2.42%
1GILD.MI (Gilead Sciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Gilead Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Gilead Sciences, Inc. was 37.97%, occurring on Dec 30, 2020. Recovery took 464 trading sessions.

The current Gilead Sciences, Inc. drawdown is 3.34%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-37.97%Apr 24, 2020176Dec 30, 2020464Oct 24, 2022640
-26.92%Dec 15, 2022319May 31, 202492Oct 9, 2024411
-22.47%Jan 30, 201867May 7, 2018455Feb 24, 2020522
-14.74%Mar 20, 20205Mar 26, 202015Apr 20, 202020
-11.67%Oct 24, 201724Nov 28, 201741Jan 29, 201865

Volatility

Volatility Chart

The current Gilead Sciences, Inc. volatility is 5.28%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%AugustSeptemberOctoberNovemberDecember2025
5.28%
3.27%
1GILD.MI (Gilead Sciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Gilead Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Gilead Sciences, Inc. compared to its peers in the Drug Manufacturers - General industry.


PE Ratio
200.0400.0600.0800.0978.8
The chart displays the price to earnings (P/E) ratio for 1GILD.MI in comparison to other companies of the Drug Manufacturers - General industry. Currently, 1GILD.MI has a PE value of 978.8. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
10.020.030.00.5
The chart displays the price to earnings to growth (PEG) ratio for 1GILD.MI in comparison to other companies of the Drug Manufacturers - General industry. Currently, 1GILD.MI has a PEG value of 0.5. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Gilead Sciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab